STRIDE - STimulating Immune Response In aDvanced brEast Cancer

NCT00925548 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in the below Purpose statement

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Tecemotide (L-BLP25) and Hormonal Treatment
BIOLOGICAL: Placebo of tecemotide (L-BLP25) and Hormonal Treatment
DRUG: cyclophosphamide
DRUG: sodium chloride (NaCl)

Sponsor

EMD Serono